| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE | 290 |
| 1 | GABAPENTIN | 165 |
| 2 | PREGABALIN | 149 |
| 3 | OXYCODONE HYDROCHLORIDE | 139 |
| 4 | ADALIMUMAB | 116 |
| 5 | FENTANYL | 115 |
| 6 | OXYCODONE | 100 |
| 7 | ETANERCEPT | 89 |
| 8 | METHOTREXATE | 78 |
| 9 | METHOTREXATE SODIUM | 78 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 51 | 0.0042 |
| 1 | BUPRENORPHINE | 290 | 0.0031 |
| 2 | ZICONOTIDE ACETATE | 6 | 0.0025 |
| 3 | ERGOCALCIFEROL | 68 | 0.0023 |
| 4 | TAPENTADOL HYDROCHLORIDE | 53 | 0.0016 |
| 5 | CARISOPRODOL | 29 | 0.0015 |
| 6 | BUPIVACAINE | 14 | 0.0015 |
| 7 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 9 | 0.0012 |
| 8 | CAPSAICIN | 4 | 0.0012 |
| 9 | FENTANYL | 115 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 290 |
| 1 | Opioid Agonist [EPC] | 237 |
| 2 | Benzodiazepine [EPC] | 188 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 173 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 152 |
| 5 | Corticosteroid [EPC] | 109 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 75 |
| 7 | Proton Pump Inhibitor [EPC] | 72 |
| 8 | Provitamin D2 Compound [EPC] | 68 |
| 9 | Vitamin C [EPC] | 64 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 290 | 0.0031 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Provitamin D2 Compound [EPC] | 68 | 0.0023 |
| 3 | Interleukin-17A Antagonist [EPC] | 62 | 0.0017 |
| 4 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 5 | Muscle Relaxant [EPC] | 50 | 0.0011 |
| 6 | Asparagine-specific Enzyme [EPC] | 13 | 0.0010 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 8 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 9 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |